Abstract C228: Preclinical analysis of therapeutic antibody efficiancy using an organoid model-based drug testing platform.
Florian T. Unger(University of Kivu), Kerstin A. David(University of Hawaiʻi at Mānoa), Christine Hein(Dermatologikum Hamburg), Jasmin Oehlmann(Dermatologikum Hamburg), Birgit Rabe(Dermatologikum Hamburg), Hartmut Juhl(Dermatologikum Hamburg), Janina Schaller, Jana Krueger(Dermatologikum Hamburg), Cordula Rosenbrock
Cited by 0
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
Detection and quantification of mutations in the plasma of patients with colorectal tumors
|Proceedings of the National Academy of Sciences|2005|1.2k
Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision
|BioTechniques|2004|229
What establishes a protein as an allergen?
|Journal of Chromatography B Biomedical Sciences and Applications|2001|111
Combined targeting of AKT and mTOR using MK‐2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma
|International Journal of Cancer|2013|88